WordNet

used to express refusal or denial or disagreement etc or especially to emphasize a negative statement; "no, you are wrong"
a negative; "his no was loud and clear"
referring to the degree to which a certain quality is present; "he was no heavier than a child" (同)no more
not in any degree or manner; not at all; "he is no better today"
quantifier; used with either mass nouns or plural count nouns for indicating a complete or almost complete lack or zero quantity of; "we have no bananas"; "no eggs left and no money to buy any"; "have you no decency?"; "did it with no help"; "Ill get you there in no time"
stated explicitly or in detail; "needed a specific amount"
a medicine that has a mitigating effect on a specific disease; "quinine is a specific for malaria"
(sometimes followed by `to'
being or affecting a disease produced by a particular microorganism or condition; used also of stains or dyes used in making microscope slides; "quinine is highly specific for malaria"; "a specific remedy"; "a specific stain is one having a specific affinity for particular structural elements"
relating to or distinguishing or constituting a taxonomic species; "specific characters"
the fifth of the seven canonical hours; about 3 p.m.

PrepTutorEJDIC

《名詞の前に置いて》『一つも』(『一人も,少しも』)・・・『ない』 / 《補語につけて》『決して・・・でない』 / 《省略文で》・・・なし;・・・お断り / 《話》少ししか(あまり)・・・ない / (肯定の問いに対して)『いいえ』;(否定の問いに対して)はい,ええ / 《not, norの前に挿入して》『いや』,否 / 《形容詞の前に置その形容詞を否定して》…どころではない / 《比較級の前に置いて》ちっとも…でない,…と全く同じ / 《… or no の形で》…であってもなくても / 《驚き・困惑・不信などを表して》とんでもない / 《単数形で》『拒否』,「『いいえ』」という返事 / 《複数形で》反対[投]票
《名詞の前にのみ用いて》『特定の』,一定の・『明確な』,明白な・(そのものに)『特有の』,独特の《+『to』+『名』》・〈C〉(…の)特効薬《+『for』+『名』》・《複数形で》明細,細部(details)

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 前立腺特異的抗原（PSA）の測定 measurement of prostate specific antigen
2. 前立腺癌のスクリーニング screening for prostate cancer
3. 少数転移（Oligometastases）を伴う非小細胞肺癌 oligometastatic non small cell lung cancer
4. 非ホジキンリンパ腫の評価および病期分類 evaluation and staging of non hodgkin lymphoma
5. 進行非小細胞肺癌：治療歴がある患者に対する二次療法 advanced non small cell lung cancer subsequent therapies for previously treated patients

Comparative intestinal esterases amongst passerine species: Assessing vulnerability to toxic chemicals in a phylogenetically explicit context.

Narvaez C1, Ramirez-Otarola N1, Bozinovic F2, Sanchez-Hernandez JC3, Sabat P4.
Chemosphere.Chemosphere.2015 Sep;135:75-82. doi: 10.1016/j.chemosphere.2015.04.016. Epub 2015 Apr 24.
Inhibition of blood esterase activities by organophosphate (OP) pesticides has been used as a sensitive biomarker in birds. Furthermore, compared to mammalian vertebrates, less is known about the role of these enzyme activities in the digestive tracts of non-mammalian vertebrates, as well as the env
PMID 25912423

Integrated sediment quality assessment through biomarker responses and bioavailability measurements: Application in Tai Lake, China.

Qi HX1, Li HZ2, Ma P1, You J3.
Ecotoxicology and environmental safety.Ecotoxicol Environ Saf.2015 Sep;119:148-54. doi: 10.1016/j.ecoenv.2015.05.007. Epub 2015 May 20.
A weight of evidence (WoE) framework has been applied to assess sediment quality of a typical freshwater lake, Tai Lake in China, where the sediments were contaminated by various chemicals but showed no acute lethality to the benthic invertebrate, Chironomus dilutus. A quantitative scoring method wa
PMID 26004354

Comparative assessment of in vitro and in vivo toxicity of azinphos methyl and its commercial formulation.

Güngördü A1, Uçkun M1.
Environmental toxicology.Environ Toxicol.2015 Sep;30(9):1091-101. doi: 10.1002/tox.21982. Epub 2014 Mar 11.
The toxic effects of Gusathion (GUS), which is a commercial organophosphate (OP) pesticide, and also its active ingredient, azinphos methyl (AzM), are evaluated comparatively with in vitro and in vivo studies. Initially, the 96-h LC50 values of AzM and GUS were estimated for two different life stage
PMID 24616035